Purification of a highly modified RNA-aptamer - Effect of complete denaturation during chromatography on product recovery and specific activity

被引:11
作者
Bridonneau, P
Bunch, S
Tengler, R
Hill, K
Carter, J
Pieken, W
Tinnermeier, D
Lehrman, R
Drolet, DW
机构
[1] NeXstar Pharmaceut Inc, Boulder, CO 80301 USA
[2] Proligo LLC, Boulder, CO 80301 USA
[3] Inhale Therapeut Syst, San Carlos, CA 94070 USA
来源
JOURNAL OF CHROMATOGRAPHY B | 1999年 / 726卷 / 1-2期
关键词
RNA-aptamers;
D O I
10.1016/S0378-4347(99)00037-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To evaluate RNA-aptamers as potential drug candidates, efficient and scaleable purification protocols are needed. Because aptamers are highly structured and rigid molecules, denaturation during the purification process is a critical aspect to obtain a pure and active product. A two-step chromatographic procedure was developed to purify a synthetic anti-VEGF aptamer at the preparative scale. A reversed-phase chromatographic step was optimized with a highly hydrophobic ion pairing reagent, followed by ion-exchange chromatography in which heat and a chaotropic salt were used. Because of the presence of 2'-modified ribose, denaturation conditions had to be optimized in both chromatographic steps to achieve a fully active molecule. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:237 / 247
页数:11
相关论文
共 40 条
  • [1] ANALYTICAL STUDY OF PHOSPHOROTHIOATE ANALOGS OF OLIGODEOXYNUCLEOTIDES USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    AGRAWAL, S
    TANG, JY
    BROWN, DM
    [J]. JOURNAL OF CHROMATOGRAPHY, 1990, 509 (02): : 396 - 399
  • [2] SEPARATION OF SYNTHETIC PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES FROM THEIR OXYGENATED (PHOSPHODIESTER) DEFECT SPECIES BY STRONG-ANION-EXCHANGE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    BERGOT, BJ
    EGAN, W
    [J]. JOURNAL OF CHROMATOGRAPHY, 1992, 599 (1-2): : 35 - 42
  • [3] High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2)
    Bridonneau, P
    Chang, YF
    O'Connell, D
    Gill, SC
    Snyder, DW
    Johnson, L
    Goodson, T
    Herron, DK
    Parma, DH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (06) : 778 - 786
  • [4] BRIDONNEAU P, IN PRESS ANTISENSE D
  • [5] USE OF THE 1-(2-FLUOROPHENYL)-4-METHOXYPIPERIDIN-4-YL (FPMP) AND RELATED PROTECTING GROUPS IN OLIGORIBONUCLEOTIDE SYNTHESIS - STABILITY OF INTERNUCLEOTIDE LINKAGES TO AQUEOUS ACID
    CAPALDI, DC
    REESE, CB
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (12) : 2209 - 2216
  • [6] RIBOZYMES AS HUMAN THERAPEUTIC AGENTS
    CHRISTOFFERSEN, RE
    MARR, JJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (12) : 2023 - 2037
  • [7] 2'-substituted phosphorothioate containing oligoribonucleotides: An application to the synthesis and purification of hammerhead ribozymes
    DiRenzo, A
    Grimm, S
    Levy, K
    Haeberli, P
    Maloney, L
    Usman, N
    Wincott, F
    [J]. NUCLEOSIDES & NUCLEOTIDES, 1996, 15 (11-12): : 1687 - 1700
  • [8] Secondary structure content of the HDV ribozyme in 95% formamide
    Duhamel, J
    Liu, DM
    Evilia, C
    Fleysh, N
    DinterGottlieb, G
    Lu, P
    [J]. NUCLEIC ACIDS RESEARCH, 1996, 24 (20) : 3911 - 3917
  • [9] LETS GET SPECIFIC - THE RELATIONSHIP BETWEEN SPECIFICITY AND AFFINITY
    EATON, BE
    GOLD, L
    ZICHI, DA
    [J]. CHEMISTRY & BIOLOGY, 1995, 2 (10): : 633 - 638
  • [10] INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS
    ELLINGTON, AD
    SZOSTAK, JW
    [J]. NATURE, 1990, 346 (6287) : 818 - 822